Committed to the fight against the emerging SARS-CoV-2 coronavirus, responsible for the ongoing pandemic of Covid-19, designated Public Health Emergency of International Concern, BioAssays submits a proposal for 21stIMI2 (Innovative Medicines Initiative) call, with a budget of €45M, for the “Development of therapeutics and diagnostics combatting coronavirus infections” within the European Horizon 2020 programme. BioAssays contributes with all its knowledge, expertise and technologies, for the development of fast and reliable diagnostic kits for not only current SARS-CoV-2 outbreak, but also future possible coronavirus outbreaks.